While IDO protein is expressed in malignant B-cells of NHL [53], and intratumoral levels are higher in lymphoma than in reactive lymph nodes, associated to poor outcome [54,55,56], in CLL IDO is produced by microenvironment cells, such as dendritic cells, macrophages and nurse-like cells [57]. This evidence concerns the gene IDO1 and non-Hodgkin lymphoma.